Table 3 Group one sub groups in COVID-19 pandemic vs Group two: laboratory findings (adjusted to age)
From: Effect of COVID-19 on Kawasaki Disease: Decrease Age of Onset and Increase Skin Manifestation
Characteristics | Before the pandemic (n = 44) | Pandemic (n = 32) | P-value (Before the pandemic vs positive COVID-19) | P-value (Before the pandemic vs COVID-19 Negative cases) | |
|---|---|---|---|---|---|
COVID-19 Positive cases (n = 22) | COVID-19 Negative cases (n = 10) | ||||
Leukocytosis | 19(43.18)% | 10(45.45)% | 3(30.00%) | 0.862 | 0.448 |
Anemia | 16(36.36%) | 7(31.81%) | 4(40.00%) | 0.716 | 0.831 |
Increased ALT | 10(22.72%) | 7(31.81%) | 4(40.0%) | 0.429 | 0.264 |
Thrombocytosis | 18(40.90%) | 8(36.36%) | 5(50.0%) | 0.724 | 0.602 |